Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutations01:39

Mutations

94.4K
Overview
94.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
DNA Packaging00:58

DNA Packaging

112.2K
Overview
112.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.7K
Chromatin Packaging01:32

Chromatin Packaging

19.0K
Each human somatic cell contains 6 billion base pairs of DNA. Each base pair is 0.34 nm long, meaning each diploid cell contains a staggering 2 meters of DNA. This long DNA strand is packed inside a nucleus measuring only 10-20 microns in diameter with the help of specialized DNA-binding proteins called histones. Together they form a compact DNA-protein complex called chromatin. The chromatin is further compacted into higher-order structures. The highest level of compaction is achieved during...
19.0K
Chromatin Packaging02:21

Chromatin Packaging

21.9K
Each human somatic cell contains 6 billion base-pairs of DNA. Each base-pair is 0.34 nm long, which means that each diploid cell contains a staggering 2 meters of DNA. How is such a long DNA strand packed inside a nucleus measuring only 10 - 20 microns in diameter? 
The chromatin
In combination with specialized DNA binding protein called Histones, the DNA double helix forms a compact DNA: protein complex called chromatin. The chromatin itself is further compacted into higher-order...
21.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for identifying functional regulatory mutation blocks by integrating genome sequencing and transcriptome data.

STAR protocols·2026
Same author

Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study.

The American journal of surgical pathology·2026
Same author

The medium-chain fatty acid octanoate is a beneficial fuel for the failing heart.

American journal of physiology. Heart and circulatory physiology·2026
Same author

BayesPI-FLY: a Bayesian neural network approach for inferring feature weighted TF-DNA interaction.

Briefings in bioinformatics·2026
Same author

Villification of the intestinal epithelium is driven by Foxl1 through activation of PDGFRα and BMPs.

Nature communications·2026
Same author

Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study.

Blood·2025

Related Experiment Video

Updated: Jan 26, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

660

BayesPI-BAR2: A New Python Package for Predicting Functional Non-coding Mutations in Cancer Patient Cohorts.

Kirill Batmanov1, Jan Delabie2, Junbai Wang1

  • 1Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

Frontiers in Genetics
|April 20, 2019
PubMed
Summary

BayesPI-BAR2 identifies functional non-coding cancer mutations by analyzing multiple mutations and patients. This tool aids in understanding gene regulation disruptions and discovering new transcription factors affected by these mutations.

Keywords:
bioinformaticscancergene regulationnon-coding mutationstranscription factors

More Related Videos

Characterization and Functional Prediction of Bacteria in Ovarian Tissues
10:12

Characterization and Functional Prediction of Bacteria in Ovarian Tissues

Published on: October 23, 2021

3.2K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.4K

Related Experiment Videos

Last Updated: Jan 26, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

660
Characterization and Functional Prediction of Bacteria in Ovarian Tissues
10:12

Characterization and Functional Prediction of Bacteria in Ovarian Tissues

Published on: October 23, 2021

3.2K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.4K

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Research

Background:

  • Most cancer-associated somatic mutations occur outside gene coding regions, potentially disrupting gene regulation via altered protein-DNA interactions.
  • Current computational tools analyze DNA sequence variants individually, complicating the identification of functional regulatory disruptions among numerous mutations.
  • Understanding these non-coding mutations is crucial for comprehending tumorigenesis.

Purpose of the Study:

  • To introduce BayesPI-BAR2, a user-friendly Python package for integrative whole-genome sequence analysis of non-coding somatic mutations.
  • To provide a novel computational tool that considers information from multiple mutations and multiple patients for predicting functional regulatory disturbances.
  • To facilitate the identification of novel transcription factors (TFs) affected by non-coding mutations in cancer.

Main Methods:

  • Development of the BayesPI-BAR2 Python package integrating gene expression, mutation spatial distribution, and a biophysical model for protein binding affinity.
  • Application of the pipeline to analyze whole-genome sequencing data from follicular lymphoma and skin cancer patients, focusing on promoter regions.
  • Evaluation of the package's ability to predict functional non-coding mutations and identify affected TFs.

Main Results:

  • BayesPI-BAR2 successfully analyzes multiple datasets of genome-wide mutations, providing interpretable reports on affected gene regulatory sites.
  • The package enables the identification of novel transcription factors whose binding is altered by non-coding mutations in cancer.
  • Demonstrated utility in follicular lymphoma and skin cancer patient cohorts.

Conclusions:

  • BayesPI-BAR2 is a valuable tool for predicting functional non-coding mutations in whole genome sequencing data.
  • The package advances the analysis of cancer genomics by considering multi-mutation and multi-patient data.
  • Facilitates discovery of new regulatory mechanisms disrupted in cancer development.